73161-19-0

Usage

Uses

Used in Organic Synthesis:
[1]BENZOTHIENO[2,3-C]PYRIDINE, 1,2,3,4-TETRAHYDROis used as a building block in organic synthesis for the creation of more complex organic molecules. Its unique ring structure allows for a variety of chemical reactions and modifications, making it a valuable component in the synthesis of advanced organic compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, [1]BENZOTHIENO[2,3-C]PYRIDINE, 1,2,3,4-TETRAHYDROis used as a starting material for the development of new pharmaceuticals. Its heterocyclic nature and potential biological activities make it an interesting candidate for the design and synthesis of novel drugs with potential therapeutic applications.
Used in Agrochemicals Development:
Similarly, [1]BENZOTHIENO[2,3-C]PYRIDINE, 1,2,3,4-TETRAHYDROmay also be utilized in the agrochemical industry as a starting material for the development of new agrochemicals. Its unique chemical structure could contribute to the creation of innovative products with enhanced properties and improved performance in agricultural applications.

Upstream product

• 73161-17-8 1,2,3,4,1',2',3',4'-octahydro-2,2'-methanediyl-bis-benzo[4,5]thieno[2,3-c]pyridine 
• 50-00-0 formaldehyd 
• 19985-71-8 2-(benzothien-3-yl)ethylamine hydrochloride 
• 3216-48-6 2-(benzo[b]thiophen-3-yl)acetonitrile 
• 920506-44-1 (2-(benzo[b]thiophen-3-yl)ethyl)carbamic acid tert-butyl ester 
• 59496-04-7 N-(2-benzo[b]thiophen-3-yl-ethyl)-formamide 
• 14585-66-1 3-(2-aminoethyl)-benzothiophene 
• 71267-72-6 3,4-dihydro-benzo[4,5]thieno[2,3-c]pyridine 

Relevant academic research and scientific papers

Substituted benzothieno [2,3-c] tetrahydropyridine derivative and preparation method and application thereof

The invention belongs to the technical field of medicinal chemistry and medicines, and relates to a substituted benzothieno [2,3-c] tetrahydropyridine derivative as shown in formula (I), a preparationmethod of the substituted benzothieno [2,3-c] tetrahydr

Discovery of novel 1,2,3,4-tetrahydrobenzo[4, 5]thieno[2, 3-c]pyridine derivatives as potent and selective CYP17 inhibitors

The inhibition of CYP17 to block androgen biosynthesis is a well validated strategy for the treatment of prostate cancer. Herein we reported the design, synthesis and structure–activity relationship (SAR) study for a series of novel 1,2,3,4- tetrahydroben

PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES

Piperazinyl oxoalkyl tetrahydro-beta-carbolines and related analogues of the formula (I): are provided, as are methods for their preparation and use. Such compounds may generally be used to modulate ligand binding to histamine H3 receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of disorders in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and therapeutic methods are provided, as are methods for using such ligands for detecting histamine H3 receptors (e.g., receptor localization studies).

FUSED HETEROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF HISTONE DEACETYLASE

Disclosed are compounds of formula (I) that inhibit histone deacetylase (HDAC) enzymatic activity, pharmaceutical compositions comprising such compounds, as well as methods to treat conditions, particularly proliferative conditions, mediated at least in part by HDAC, wherein A, W, W1, W2, Ar2, and G are described herein.